These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11019532)

  • 21. [Comparative evaluation of antianginal efficacy of isosorbide dinitrate in various doses in patients with stable angina].
    Kośmicki M; Sadowski Z
    Wiad Lek; 2000; 53(7-8):388-93. PubMed ID: 11070759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical effect of nitrates (Olicard 40) and their influence on deforming of erythrocytes against the background of 24-hour catecholaminuria].
    Dłuźniewski M; Lada W; Raczkowska A; Mamcarz A; Podogrodzka B; Swiatowiec A; Jurgiel R; Sitkiewicz W; Pawińska M
    Wiad Lek; 1994 Sep; 47(17-18):641-8. PubMed ID: 7571611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-angina treatment in stable forms of angina pectoris with emphasis on nitrates].
    Murín J
    Vnitr Lek; 1999 Feb; 45(2):122-6. PubMed ID: 15641233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic management of chronic stable angina.
    Dixit D; Kimborowicz K
    JAAPA; 2015 Jun; 28(6):. PubMed ID: 25989429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tolerance to nitrates in patients with angina and effect of plasmapheresis].
    Koziolova NA
    Ter Arkh; 2001; 73(12):21-5. PubMed ID: 11858102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
    Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
    Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The evaluation of the antianginal effect of Corvaton-Retard in patients with ischemic heart disease by using paired bicycle ergometry].
    Runovich AA; Verkhozin IA; Kuril'skaia TE; Zuev AV
    Ter Arkh; 1997; 69(9):51-2. PubMed ID: 9411828
    [No Abstract]   [Full Text] [Related]  

  • 28. [Dilzem-retard efficiency in patients with ischemic heart disease and heart failure].
    Gadzhiev AN
    Klin Med (Mosk); 2002; 80(6):45-8. PubMed ID: 12138803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute effect of isosorbide mononitrate on blood circulation and myocardial ischemia in patients with atherosclerosis].
    Solimene MC
    Arq Bras Cardiol; 1995 Jul; 65(1):79-80. PubMed ID: 8546602
    [No Abstract]   [Full Text] [Related]  

  • 30. Isosorbide dinitrate in the treatment of anal fissure: a randomised, prospective, double blind, placebo-controlled trial.
    Werre AJ; Palamba HW; Bilgen EJ; Eggink WF
    Eur J Surg; 2001 May; 167(5):382-5. PubMed ID: 11419556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Withdrawal of intravenous glyceryl trinitrate: absence of rebound phenomena with transition to oral isosorbide dinitrate.
    Kelly EA; Ahmed RM; Horowitz JD
    Clin Exp Pharmacol Physiol; 2005 Apr; 32(4):269-72. PubMed ID: 15810990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Quality of life of patients with ischemic heart disease taking isosorbide-5-mononitrate in an outpatient setting].
    Popov KV; Kuimov AD
    Kardiologiia; 2003; 43(7):53-4. PubMed ID: 14603907
    [No Abstract]   [Full Text] [Related]  

  • 33. [Mono Mac 50D treatment results in patients with chronic coronary heart disease].
    Khurs EM; Antiuf'ev VF
    Klin Med (Mosk); 2001; 79(9):58-60. PubMed ID: 11641941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative antianginal efficiency of prolonged nitrites in patients treated surgically for ischemic heart disease].
    Kosov VA; Podshibiakin SE; Nagatkin AN
    Klin Med (Mosk); 2000; 78(9):50-2. PubMed ID: 11051742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Specific features of lipid atherogenic modification in patients with ischemic heart disease and diabetes mellitus].
    Syrkin AL; Azizova OA; Drinitsina SV; Solovi'eva NP; Frenkel' EE; Savchenkova AP; Kliuchnikova TI
    Klin Med (Mosk); 2001; 79(4):25-9. PubMed ID: 11496733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significant labeling and dosing changes for isosorbide dinitrate.
    Drown DJ
    Prog Cardiovasc Nurs; 1997; 12(4):32-3. PubMed ID: 9433732
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of therapy with various groups of antianginal agents on life quality of the elderly with coronary heart disease and comorbid depression].
    Shangina OA; Kostin VI; Koturga LI
    Klin Med (Mosk); 2005; 83(7):34-7. PubMed ID: 16117422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of the preparation Iso Mack Retard 60 mg I 120 mg in the treatment of patients with advanced ischemic heart disease].
    Markiewicz M; Jach A; Wysokiński A
    Wiad Lek; 1992 Nov; 45(21-22):803-5. PubMed ID: 1299035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and cost-effective aspects of nitrate therapy in patients with ischemic heart disease after aortocoronary bypass surgery].
    Kosov VA; Zamotaev IuN; Kremnev IuA
    Klin Med (Mosk); 2001; 79(11):32-5. PubMed ID: 11811105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Various forms of mononitrates in treating patients with stress angina].
    Lupanov VP; Kazachkina SS; Naumov VG
    Ter Arkh; 2003; 75(1):40-5. PubMed ID: 12652955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.